News & Activities

ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme - ProBio

SunRock Biopharma and ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program

ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology

Through strategic collaboration with ProBio, Initium Therapeutics plans to utilize ProBio’s Berkeley Lights Beacon platform to expand their antibody drug pipeline.

Serving a Rising Power

ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded

ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC - ProBio

ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program - ProBio

ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. - ProBio

ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes - ProBio

Beroni Group Signs Agreement with ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19 - ProBio

GenScript launches CDMO segment ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum - ProBio

GenScript launches CDMO segment ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum - ProBio

GenScript and Selecxine Enter Into Strategic Cooperation Agreement - ProBio

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation - ProBio

GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma - ProBio

GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation - ProBio

Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center - ProBio